Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 02 Jan 2025

Unveiling the role of ASPP1 in cancer progression: pan-cancer bioinformatics and experimental validation in colorectal cancer

in Cancer Molecular Targets and Therapeutics

Keyuan Xiao
Xiang Li
Ihsan Ullah
Wenqing Hu
Kaiqiang Wang
Fan Yang
Chengyu Yang
Chunqi Feng
Liang Zong
Xinghua Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1529809

1,495 views

Original Research

Published on 24 Dec 2024

PGD2/PTGDR2 signaling pathway affects the self-renewal capacity of gastric cancer stem cells by regulating ATG4B ubiquitination

in Cancer Molecular Targets and Therapeutics

Qiang Zhang
HengJin Tian
Kunpeng Ge
FeiFan Wang
PeiYao Gao
AMin Chen
Lulu Wang
YanMing Zhao
Chaoqun Lian
FengChao Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1496050

1,062 views

Review

Published on 24 Dec 2024

Diagnostic and therapeutic role of non-coding RNAs regulating programmed cell death in melanoma

in Cancer Molecular Targets and Therapeutics

Zixu Wang
Cong Xie
Xiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1476684

1,979 views
1 citation

Original Research

Published on 24 Dec 2024

The bioinformatics analysis and experimental validation of the carcinogenic role of EXO1 in lung adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Bohao Sun
Jing Zhang
Nan Wang
Zhirong Zhang
Yichen Wu
Mengzhen Xie
Yanmei Peng
Yifan Ye
Zhaochang Jiang
Shumei Wei

Frontiers in Oncology

doi 10.3389/fonc.2024.1492725

1,802 views

Original Research

Published on 23 Dec 2024

Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation

in Cancer Molecular Targets and Therapeutics

Rati Lama
Wenjie Wu
Cory K. Mavis
Federico M. Ruiz
Javier Querol-García
Diana Martin
Sherry R. Chemler
Dhyan Chandra
David W. Goodrich
Francisco J. Hernandez-Ilizaliturri

Frontiers in Oncology

doi 10.3389/fonc.2024.1462231

1,240 views
1 citation

Original Research

Published on 20 Dec 2024

Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer

in Cancer Molecular Targets and Therapeutics

Yun Tian
Xiabing Li
Hongjian Zhang
Yaping Wang
Hongyu Li
Qiaohong Qin

Frontiers in Oncology

doi 10.3389/fonc.2024.1494051

984 views

Systematic Review

Published on 20 Dec 2024

Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Wenjun Meng
Yihang Luo
Lu Zhao
Yaoyu Zhang
Jiyan Liu
Shadan Li
Yang Du
Hongshuai Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1507608

3,546 views

Case Report

Published on 17 Dec 2024

A good response to furmonertinib fourth-line treatment of an advanced lung adenocarcinoma patient with EGFR exon20in and PIK3CA mutation: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Kai Sun
Peng Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1467722

2,167 views

Original Research

Published on 17 Dec 2024

Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p

in Cancer Molecular Targets and Therapeutics

Guodong Huang
Yuxia Liu
Lisha Li
Bing Li
Ting Jiang
Yufeng Cao
Xiaoping Yang
Xinning Liu
Honglin Qu
Shitao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1508715

1,324 views

Review

Published on 16 Dec 2024

Unraveling IFI44L’s biofunction in human disease

in Cancer Molecular Targets and Therapeutics

Juan Du
Hui Luo
Shuang Ye
Hui Zhang
Zhen Zheng
Kaitai Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1436576

2,182 views
3 citations

Original Research

Published on 16 Dec 2024

Hyaluronic acid–targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals

in Cancer Molecular Targets and Therapeutics

Gangqiang Xue
Lu Tang
Xinyan Pan
Sanni Li
Juan Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1520274

1,063 views
1 citation

Review

Published on 16 Dec 2024

Research progress and treatment status of malignant ascites

in Cancer Molecular Targets and Therapeutics

Jing He
Hui-ping Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390426

2,299 views

Mini Review

Published on 13 Dec 2024

ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target

in Cancer Molecular Targets and Therapeutics

Tonglin Sun
Xi Li
Yi Zhang
Bingwen Zou
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1513979

2,130 views
1 citation

Review

Published on 12 Dec 2024

Molecular glue degrader for tumor treatment

in Cancer Molecular Targets and Therapeutics

Yuhan Hu
Yan Yan
Jiehao Wang
Jiangxue Hou
Quande Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1512666

5,049 views
4 citations

Correction

Published on 11 Dec 2024

Corrigendum: Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

in Cancer Molecular Targets and Therapeutics

Fatemeh Yazarlou
Ivan Martinez
Leonard Lipovich

Frontiers in Oncology

doi 10.3389/fonc.2024.1507032

700 views

Original Research

Published on 06 Dec 2024

Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11

in Cancer Molecular Targets and Therapeutics

Vid Mlakar
Ina Oehme
Laurence Lesne
Sara Najafi
Marc Ansari
Fabienne Gumy-Pause

Frontiers in Oncology

doi 10.3389/fonc.2024.1433256

1,786 views